Tag: Relapsed refractory myeloma options

Home / Relapsed refractory myeloma options

Categories

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

OriCAR-017 for RRMM A top biopharmaceutical company in the clinical stage, Oricell Therapeutics, shared the long-term follow-up results of OriCAR-017, a Phase I study that looked at how well GPRC5D-t...
relapsed-refractory-myeloma-options

Scan the code